Rafarma Pharmaceuticals Market Cap

Rafarma Pharmaceuticals has a market cap or net worth of $8.32 million as of May 28, 2025. Its market cap has decreased by -60.38% in one year.

Market Cap

8.32M

Enterprise Value

n/a

Revenue

133.33K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.09

Market Cap Chart

Since October 18, 2012, Rafarma Pharmaceuticals's market cap has decreased from 20.34M to 8.32M, a decrease of -59.09%. That is a compound annual growth rate of -6.85%.

Market Cap History

Date	Market Cap	% Change
May 23, 2025	9.06M	33.66%
Dec 31, 2024	6.78M	-70.44%
Dec 29, 2023	22.93M	-40.44%
Dec 30, 2022	38.51M	-47.44%
Dec 31, 2021	73.26M	-47.17%
Dec 31, 2020	138.67M	273.04%
Dec 31, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 27, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	747.23M
Nika Pharmaceuticals	672.83M
Tian'an Technology Group	591.73M
Elite Pharmaceuticals	565.54M
Glass House Brands	452.21M
CytoDyn	423.89M
Northwest Biotherapeutics	399.83M

Market Cap Rankings